+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Condylomata Acuminata Drug"

Genital Warts Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Genital Warts Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 57 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Condylomata Acuminata is a sexually transmitted infection caused by the human papillomavirus (HPV). It is characterized by the presence of warts on the genitals, anus, and surrounding areas. Treatment for this infection typically involves the use of antiviral drugs, topical creams, and cryotherapy. The Infectious Diseases Drugs market for Condylomata Acuminata is composed of a variety of pharmaceutical companies that specialize in the development and manufacture of drugs to treat this condition. These companies are focused on providing effective treatments that are safe and well-tolerated by patients. Some of the companies in this market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. These companies are committed to providing innovative treatments that can help patients manage their condition and improve their quality of life. Show Less Read more